ArcelorMittal Prices Offering Of $2.2 Bln Notes

Steel major ArcelorMittal S.A. (MT) said on Tuesday that it has priced an offering of $1.2 billion, 6.550 percent notes due 2027, and $1 billion, 6.800 percent due 2032.

The steel manufacturing major intends to use proceeds from the offering for general corporate purposes.

The offering is expected to be closed on November 29.

ArcelorMittal also noted that the upon the closing of transaction, commitments which are available under a $2.2 billion bridge term facility deal with a financial provider for the proposed acquisition of Companhia Siderúrgica do Pecém will be cancelled.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT